How it works
The Medcheck report uses a cloud-based pharmacogenomics interpretation system underpinned by data from numerous research papers and clinical trials, positioning it as an essential evidence-based strategy for improving the use of medications.
The report contains pharmacogenomic guidelines developed by the Clinical Pharmacogenetics Implementation Consortium (CPIC), the Dutch Pharmacogenetics Working Group (DPWG), the Food and Drug Administration (FDA) and many others.
The data presented on the Medcheck reports is credible, evidence based, regularly updated and vigorously vetted through an experienced medical department.
What does it test?
Medcheck analyses genotypes associated with responsiveness to approximately 150 medications covering cardiovascular, psychiatry and pain medications. Some examples:
The future of medicine is personalised
Traditionally, the approach to medication has been ‘one dose fits all’. But everyone’s genetic make-up is different. Which means the way you metabolise medication is unique. This can lead to negative side-effects or ineffectiveness of certain medications.
By analysing the unique ways your body processes medication and adjusting treatment accordingly, you can increase the effectiveness of your medication. Medical practitioners can also benefit by prescribing treatment that yields better results and avoid a trial and error approach to treating you. This is what’s known as personalised medicine.
For more information about personalised medicine, download the Medcheck brochure.